肝母细胞瘤保留实质切除的肿瘤预后。

IF 2.5 2区 医学 Q1 PEDIATRICS
Brian T Hickner, Andres F Espinoza, Prakash M Masand, Dolores H Lopez-Terrada, Valeria R Smith, Sarah S Kappa, Ekene A Onwuka, Jed G Nuchtern, Sanjeev A Vasudevan
{"title":"肝母细胞瘤保留实质切除的肿瘤预后。","authors":"Brian T Hickner, Andres F Espinoza, Prakash M Masand, Dolores H Lopez-Terrada, Valeria R Smith, Sarah S Kappa, Ekene A Onwuka, Jed G Nuchtern, Sanjeev A Vasudevan","doi":"10.1016/j.jpedsurg.2026.163195","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Surgery is the cornerstone of therapy for hepatoblastoma (HB). While standard resection (SR) via hemi-hepatectomy and trisectionectomy has traditionally been the preferred surgical approach, parenchyma-sparing resection (PSR) has become increasingly popular. We sought to compare the characteristics and outcomes of patients who underwent PSR versus SR.</p><p><strong>Methods: </strong>Single-institution retrospective cohort study of HB patients who underwent hepatectomy from February 8, 2012 to August 12, 2024. Patients with metastasis at diagnosis, who underwent transplant, or who received simultaneous SR and PRS were excluded. Primary outcomes included 5-year event-free (EFS) and overall survival (OS). Secondary outcomes included margin status, transfusion requirement, operative time, postoperative liver dysfunction, reoperation, and biliary complications.</p><p><strong>Results: </strong>Forty-three patients met inclusion criteria (21 PSR, 22 SR). More patients in the PSR group presented with pre-treatment extent of disease (PRETEXT) I tumors, multifocal disease or underwent upfront resection, whereas the SR group more frequently displayed aggressive histology. No events were observed in the PSR cohort at a median follow-up of 4.8 years, corresponding to 100% estimated 5-year EFS and OS. The estimated 5-year EFS and OS in the SR cohort were 87%; however when controlling for histology, the EFS and OS was equivalent to the PSR group. Two patients in the PSR group had microscopically positive resection margins compared to none in the SR group. PSR was associated with lower intra- and postoperative transfusion requirements, shorter operative times, and less severe postoperative liver dysfunction.</p><p><strong>Conclusion: </strong>In this single-institution retrospective study, PSR was associated with acceptable oncologic outcomes in spite of two patients having microscopically positive margins. In select patients with low PRETEXT stage, multifocal tumors, and favorable vascular relationships, PSR may represent a viable surgical option when technically feasible and within surgeon expertise.</p>","PeriodicalId":16733,"journal":{"name":"Journal of pediatric surgery","volume":" ","pages":"163195"},"PeriodicalIF":2.5000,"publicationDate":"2026-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma.\",\"authors\":\"Brian T Hickner, Andres F Espinoza, Prakash M Masand, Dolores H Lopez-Terrada, Valeria R Smith, Sarah S Kappa, Ekene A Onwuka, Jed G Nuchtern, Sanjeev A Vasudevan\",\"doi\":\"10.1016/j.jpedsurg.2026.163195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Surgery is the cornerstone of therapy for hepatoblastoma (HB). While standard resection (SR) via hemi-hepatectomy and trisectionectomy has traditionally been the preferred surgical approach, parenchyma-sparing resection (PSR) has become increasingly popular. We sought to compare the characteristics and outcomes of patients who underwent PSR versus SR.</p><p><strong>Methods: </strong>Single-institution retrospective cohort study of HB patients who underwent hepatectomy from February 8, 2012 to August 12, 2024. Patients with metastasis at diagnosis, who underwent transplant, or who received simultaneous SR and PRS were excluded. Primary outcomes included 5-year event-free (EFS) and overall survival (OS). Secondary outcomes included margin status, transfusion requirement, operative time, postoperative liver dysfunction, reoperation, and biliary complications.</p><p><strong>Results: </strong>Forty-three patients met inclusion criteria (21 PSR, 22 SR). More patients in the PSR group presented with pre-treatment extent of disease (PRETEXT) I tumors, multifocal disease or underwent upfront resection, whereas the SR group more frequently displayed aggressive histology. No events were observed in the PSR cohort at a median follow-up of 4.8 years, corresponding to 100% estimated 5-year EFS and OS. The estimated 5-year EFS and OS in the SR cohort were 87%; however when controlling for histology, the EFS and OS was equivalent to the PSR group. Two patients in the PSR group had microscopically positive resection margins compared to none in the SR group. PSR was associated with lower intra- and postoperative transfusion requirements, shorter operative times, and less severe postoperative liver dysfunction.</p><p><strong>Conclusion: </strong>In this single-institution retrospective study, PSR was associated with acceptable oncologic outcomes in spite of two patients having microscopically positive margins. In select patients with low PRETEXT stage, multifocal tumors, and favorable vascular relationships, PSR may represent a viable surgical option when technically feasible and within surgeon expertise.</p>\",\"PeriodicalId\":16733,\"journal\":{\"name\":\"Journal of pediatric surgery\",\"volume\":\" \",\"pages\":\"163195\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2026-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pediatric surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jpedsurg.2026.163195\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pediatric surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jpedsurg.2026.163195","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

目的:手术是肝母细胞瘤(HB)治疗的基石。虽然通过半肝切除和三节切除的标准切除(SR)传统上是首选的手术方法,但保留实质切除(PSR)已越来越受欢迎。我们试图比较PSR和sr患者的特征和结果。方法:对2012年2月8日至2024年8月12日接受肝切除术的HB患者进行单机构回顾性队列研究。排除诊断时有转移的患者,接受移植的患者,或同时接受SR和PRS的患者。主要结局包括5年无事件(EFS)和总生存期(OS)。次要结局包括切缘状况、输血需求、手术时间、术后肝功能障碍、再手术和胆道并发症。结果:43例患者符合纳入标准(PSR 21例,SR 22例)。PSR组更多的患者出现治疗前病变程度(托普I)肿瘤、多灶性疾病或进行了前期切除,而SR组更多的患者表现为侵袭性组织学。在中位随访4.8年的PSR队列中未观察到任何事件,对应于100%的估计5年EFS和OS。SR队列的5年估计EFS和OS为87%;然而,当控制组织学时,EFS和OS与PSR组相当。PSR组有2例患者显微镜下切除边缘阳性,而SR组无一例。PSR与较低的内、术后输血需求、较短的手术时间和较轻的术后肝功能障碍有关。结论:在这项单机构回顾性研究中,PSR与可接受的肿瘤预后相关,尽管两名患者的显微边缘呈阳性。在低托普期、多灶性肿瘤和良好血管关系的患者中,PSR可能是一种可行的手术选择,如果技术可行,并且在外科医生的专业知识范围内。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma.

Purpose: Surgery is the cornerstone of therapy for hepatoblastoma (HB). While standard resection (SR) via hemi-hepatectomy and trisectionectomy has traditionally been the preferred surgical approach, parenchyma-sparing resection (PSR) has become increasingly popular. We sought to compare the characteristics and outcomes of patients who underwent PSR versus SR.

Methods: Single-institution retrospective cohort study of HB patients who underwent hepatectomy from February 8, 2012 to August 12, 2024. Patients with metastasis at diagnosis, who underwent transplant, or who received simultaneous SR and PRS were excluded. Primary outcomes included 5-year event-free (EFS) and overall survival (OS). Secondary outcomes included margin status, transfusion requirement, operative time, postoperative liver dysfunction, reoperation, and biliary complications.

Results: Forty-three patients met inclusion criteria (21 PSR, 22 SR). More patients in the PSR group presented with pre-treatment extent of disease (PRETEXT) I tumors, multifocal disease or underwent upfront resection, whereas the SR group more frequently displayed aggressive histology. No events were observed in the PSR cohort at a median follow-up of 4.8 years, corresponding to 100% estimated 5-year EFS and OS. The estimated 5-year EFS and OS in the SR cohort were 87%; however when controlling for histology, the EFS and OS was equivalent to the PSR group. Two patients in the PSR group had microscopically positive resection margins compared to none in the SR group. PSR was associated with lower intra- and postoperative transfusion requirements, shorter operative times, and less severe postoperative liver dysfunction.

Conclusion: In this single-institution retrospective study, PSR was associated with acceptable oncologic outcomes in spite of two patients having microscopically positive margins. In select patients with low PRETEXT stage, multifocal tumors, and favorable vascular relationships, PSR may represent a viable surgical option when technically feasible and within surgeon expertise.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
12.50%
发文量
569
审稿时长
38 days
期刊介绍: The journal presents original contributions as well as a complete international abstracts section and other special departments to provide the most current source of information and references in pediatric surgery. The journal is based on the need to improve the surgical care of infants and children, not only through advances in physiology, pathology and surgical techniques, but also by attention to the unique emotional and physical needs of the young patient.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书